Juno Therapeutics (JUNO) is traded on NASDAQ in USA. It is located in WASHINGTON, U.S.A and employs 589 people. Juno Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 10.1 B. Juno Therapeutics conducts business under Healthcare
sector and is part of Biotechnology
industry. This company has 116.11 M outstanding shares of which 8.19 M shares are currently shorted by private and institutional investors with about 3.36 trading days to cover.
currently holds about 927.53 M in cash with (201.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.18.
Check Juno Therapeutics Probability Of Bankruptcy